中国学者近期发表的论文
1.	Cellular Senescence-Inducing Small Molecules for Cancer Treatment. Author: Liu P1, Lu Z2, Wu Y1, Shang D1,2, Zhao Z2, Shen Y2, Zhang Y2, Zhu F1, Liu H2, Tu Z1. Journal: Curr Cancer Drug Targets. 2019;19(2):109-119. doi: 10.2174/1568009618666180530092825.    PubMed      DOI
2.	Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery. Author: Xie X1, Zhang Y1, Li F1, Lv T1, Li Z1, Chen H1, Jia L1, Gao Y1. Journal: Curr Cancer Drug Targets. 2019;19(4):257-276. doi: 10.2174/1568009618666180628160211.    PubMed      DOI
3.	Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension. Author: Cao Y1, Wei Z1, Li M1, Wang H1, Yin L1, Chen D1, Wang Y1, Chen Y1, Yuan Q1, Pu X1, Zong L1,2, Duan S1. Journal: Curr Cancer Drug Targets. 2019;19(4):338-347. doi: 10.2174/1568009618666180629150927.    PubMed      DOI
4.	Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer. Author: Chen J1,2, Niu N2, Zhang J3, Qi L2,4, Shen W2,5, Donkena KV2, Feng Z1, Liu J2. Journal: Curr Cancer Drug Targets. 2019;19(5):360-367. doi: 10.2174/1568009618666180703154233.    PubMed      DOI
5.	Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells. Author: Jiang Z1, Ye J2, Yang J1, Wang J2, Jia L1, Ho RJ3. Journal: Curr Cancer Drug Targets. 2019;19(4):312-320. doi: 10.2174/1568009618666180706164046.    PubMed      DOI
6.	Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer. Author: Liu P1, Tang H1, Wu J1, Qiu X2, Kong Y1, Zhang L1, Xie X1, Xiao X1. Journal: Curr Cancer Drug Targets. 2019;19(1):74-80. doi: 10.2174/1568009618666180709163718.    PubMed      DOI
7.	The Evaluation of Animal Models in the Development of Anticancer Agents: From Preclinical to Clinical Tests. Author: Wang J1, Dong H2, Liu J1, Zheng N1, Xie X1, Jia L1,3. Journal: Curr Cancer Drug Targets. 2019;19(4):277-284. doi: 10.2174/1568009618666180817095331.    PubMed      DOI
8.	Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study. Author: Tania M1, Shawon J1,2, Saif K1,2, Kiefer R3, Khorram MS4, Halim MA1, Khan MA1,5. Journal: Curr Cancer Drug Targets. 2019;19(2):152-159. doi: 10.2174/1568009618666180905095356.    PubMed      DOI
9.	In Vitro and In Vivo Antimetastatic Effects of ZSTK474 on Prostate Cancer DU145 Cells. Author: Liu J1,2, Tan X1,2,3, Zhao W1,2, Liu J1,2,3, Xing X4, Fan G4, Zhang P5, Zhang Z1, Zhong Y3, Kong D1,2. Journal: Curr Cancer Drug Targets. 2019;19(4):321-329. doi: 10.2174/1568009618666180911101310.    PubMed      DOI
10.	The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy. Author: Yin Y1, Qi X1, Qiao Y1, Liu H2, Yan Z1, Li H3, Liu Z1. Journal: Curr Cancer Drug Targets. 2019;19(1):50-64. doi: 10.2174/1568009618666181003170027.    PubMed      DOI

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 160.19 Nature Reviews Clinical Oncology 127 8.04 NATURE REVIEWS CANCER 396 23.23 LANCET ONCOLOGY 274 10.07 JOURNAL OF CLINICAL ONCOLOGY 494 11.08 CANCER CELL 295 15.04 ANNALS OF ONCOLOGY 210 8.44 SEMINARS IN CANCER BIOLOGY 134 8.86 CLINICAL CANCER RESEARCH 292 8.32 CANCER RESEARCH 411 6.94

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 288307 CANCER RESEARCH 163852 International Journal of Nanomedicine 162348 Molecular Medicine Reports 162265 CANCER LETTERS 157413 JOURNAL OF ETHNOPHARMACOLOGY 139272 BIOMEDICINE & PHARMACOTHERAPY 137350 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133938 Theranostics 133230 International Journal of Environmental Research and Public Health 131546